Search Results 1011-1020 of 37968 for Two-phase
Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...
The primary objective of study Part A is to assess the safety of talacotuzumab (formerly CSL362) monotherapy and confirm the recommended Phase 2 dose (RP2D) in ...
Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. ... This phase III clinical trial studies two different dose ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of Phase II part 2 is to compare the Progression-Free Survival (PFS) of TG4001 in combination with avelumab vs avelumab alone in patients with ...
Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...
The female reproductive system contains two ovaries, one on each side of the uterus. ... These rare tumors are usually diagnosed at an earlier stage than other ...
About this study. This phase III clinical trial studies two different dose schedules of paclitaxel to see how well they work in combination with carboplatin ...
Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a ... 2 Negative, Early-Stage Breast Cancer. JCO Precis Oncol. 2025 Aug; 9 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.